文献速递肝病

非酒精性脂肪性肝病的遗传通路:系统生物学视角

Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology.
PubMed 文献 · Hepatology · 2020-01-01

本文综述了人类非酒精性脂肪性肝病(NAFLD)的主要通路和已知的关键遗传修饰因子,并构建了系统生物学预测模型(NAFLD-Reactome),将PNPLA3、TM6SF2、MBOAT7、GCKR和HSD17B13等变异与NAFLD关联,扩展了相关机制,为假设检验和药物靶点发现提供平台。

要点

  • PNPLA3、TM6SF2、MBOAT7、GCKR和HSD17B13等变异是NAFLD的主要遗传修饰因子。
  • 这些变异作用于从头脂肪生成底物供应、线粒体能量利用、脂滴组装与脂解、VLDL组装分泌等通路。
  • NAFLD-Reactome模型可扩展通路并用于假设检验和可成药靶点发现。

核心结论

  • NAFLD的遗传结构涉及多个主要通路和候选基因变异,系统生物学模型有助于整合这些通路并指导未来研究和药物干预。

研究设计与样本

  • 综述类文章,未报告系统检索范围。

主要发现

  • PNPLA3、TM6SF2、MBOAT7、GCKR和HSD17B13等基因变异与NAFLD相关。
  • 这些变异在从头脂肪生成底物供应、线粒体能量利用、脂滴组装与脂解及脂肪酸区室化、VLDL组装与分泌等不同通路中发挥作用。
  • NAFLD-Reactome预测模型扩展了已知通路,并可作为可成药靶点发现平台。

临床怎么用

  • 遗传变异信息有助于理解NAFLD发病机制,但本文未提供具体临床推荐或阈值。

局限性

  • 本文未系统报告所综述研究的样本量、效应值或统计学显著性,且预测模型需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonalcoholic fatty liver disease (NAFLD) represents a burgeoning worldwide epidemic whose etiology reflects multiple interactions between environmental and genetic factors. Here, we review the major pathways and dominant genetic modifiers known to be relevant players in human NAFLD and which may determine key components of the heritability of distinctive disease traits including steatosis and fibrosis. In addition, we have employed general assumptions which are based on known genetic factors in NAFLD to build a systems biology prediction model that includes functional enrichment. This prediction model highlights additional complementary pathways that represent plausible intersecting signaling networks that we define here as an NAFLD-Reactome. We review the evidence connecting variants in each of the major known genetic modifiers (variants in patatin-like phospholipase domain containing 3, transmembrane 6 superfamily member 2, membrane-bound O-acyltransferase domain containing 7, glucokinase regulator, and hydroxysteroid 17-beta dehydrogenase 13) to NAFLD and expand the associated underlying mechanisms using functional enrichment predictions, based on both preclinical and cell-based experimental findings. These major candidate gene variants function in distinct pathways, including substrate delivery for de novo lipogenesis; mitochondrial energy use; lipid droplet assembly, lipolytic catabolism, and fatty acid compartmentalization; and very low-density lipoprotein assembly and secretion. The NAFLD-Reactome model expands these pathways and allows for hypothesis testing, as well as serving as a discovery platform for druggable targets across multiple pathways that promote NAFLD development and influence several progressive outcomes. In conclusion, we summarize the strengths and weaknesses of studies implicating selected variants in the pathophysiology of NAFLD and highlight opportunities for future clinical research and pharmacologic intervention, as well as the implications for clinical practice.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Sookoian S, Pirola CJ, Valenti L, et al. Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology. Hepatology. 2020. PMID: 32170962. doi:10.1002/hep.31229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。